Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch
Recruiting
N/A
Interventional Study
Cardiac Arrhythmia
Diagnostic/Monitoring Devices Related to Adverse Incidents
Atrial Fibrillation (AF)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 22 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 300 (estimated)
- Sponsor
- HelpWear Inc. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available m…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* At least 22 years of age at time of consent
* Clinically indicated for a Holter monitor test
* Able to wear the HeartWatch on the left bicep for the study duration
* Able to follow the protocol
* No functional implantable pacemaker or defibrillator
* Left bicep circumference \…
Contacts